KRM Ayurveda IPO Allotment Expected Today After Massive Subscription
The initial public offering (IPO) of hospital chain operator KRM Ayurveda Ltd has concluded with an overwhelming response from investors, receiving subscriptions more than 74 times the offered shares. With the bidding period now closed, market participants are eagerly awaiting the KRM Ayurveda IPO allotment, which is anticipated to take place today, January 27, 2026.
IPO Timeline and Key Dates
The SME IPO was open for subscription from January 21 to January 23, 2026. Following the allotment process, the company is expected to finalize the basis of share allocation shortly. Once completed, equity shares will be credited to the demat accounts of successful allottees, while refunds will be initiated for unsuccessful bidders on January 28, 2026. The official IPO listing date is set for January 29, 2026, with KRM Ayurveda shares scheduled to be listed on the NSE SME platform.
How to Check Allotment Status
Investors can verify their KRM Ayurveda IPO allotment status through two primary channels:
- Via NSE Website:
- Visit the NSE allotment status page.
- Select 'Equity and SME IPO bids'.
- Choose 'KRM Ayurveda Limited' from the Issue Name dropdown.
- Enter your PAN and Application Number.
- Click Submit to view your status.
- Via Registrar Skyline Financial Services:
- Access the IPO registrar's website.
- Select 'KRM Ayurveda Limited' from the company dropdown.
- Enter your DPID/Client ID, Application Number, or PAN.
- Click Search to display your allotment details.
Skyline Financial Services Pvt. Ltd. serves as the official registrar for this IPO, while NEXGEN Financial Solutions Pvt. Ltd. acted as the book running lead manager.
Grey Market Premium and Subscription Details
In the unlisted market, KRM Ayurveda shares are commanding a grey market premium (GMP) of ₹20 per share. This suggests that the shares are trading at a premium in the grey market, with an estimated listing price of around ₹155 per share. This represents a premium of approximately 15% over the IPO price band of ₹128 to ₹135 per share.
The IPO subscription data reveals robust demand across investor categories:
- Total Subscription: 74.27 times
- Retail Individual Investors (RII): 54.21 times
- Qualified Institutional Buyers (QIB): 63.31 times
- Non-Institutional Investors (NII): 135.37 times
The company successfully raised ₹77.49 crore through this book-building issue, which comprised entirely a fresh issue of 57.40 lakh equity shares. This strong investor appetite underscores the market's confidence in KRM Ayurveda's growth prospects within the healthcare and Ayurveda sectors.
